G
Guobang Pharma Ltd
SSE:605507
Guobang Pharma Ltd
SSE:605507
Price:
25.57
CNY
-0.51%
Market Closed
Market Cap:
¥14.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Guobang Pharma Ltd
SSE:605507
|
CN |
|
S
|
Sparx Technology Inc
XTSX:SPRX
|
CA |
|
BTS Group AB
STO:BTS B
|
SE |
|
P
|
Planet 13 Holdings Inc
CNSX:PLTH
|
US |
|
H
|
Henan Yuneng Holdings Co Ltd
SZSE:001896
|
CN |
|
C
|
Citic Offshore Helicopter Co Ltd
SZSE:000099
|
CN |
|
G
|
Guangdong Tecsun Science & Technology Co Ltd
SZSE:002908
|
CN |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
|
A
|
AMCON Distributing Co
AMEX:DIT
|
US |
|
HBL Power Systems Ltd
NSE:HBLPOWER
|
IN |
|
Soundwill Holdings Ltd
HKEX:878
|
HK |
Multiples-Based Value
The Multiples-Based Value for Guobang Pharma Ltd (605507) under the Base Case is hidden CNY. Compared with the current market price of 25.57 CNY, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Guobang Pharma Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Guobang Pharma Ltd Competitors
Guobang Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
G
|
Guobang Pharma Ltd
SSE:605507
|
14.3B CNY | 2.4 | 16.4 | 13.8 | 13.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
887.6B USD | 13.6 | 43 | 29 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.2B GBP | 5.3 | 30.2 | 16.7 | 23.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.5 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
300.5B USD | 4.6 | 16.5 | 10.2 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.1B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.7B GBP | 2.7 | 15.4 | 8.4 | 10.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
